ANI Pharmaceuticals Inc (NAS:ANIP)
$ 54.41 -1.09 (-1.96%) Market Cap: 1.14 Bil Enterprise Value: 1.64 Bil PE Ratio: 0 PB Ratio: 2.82 GF Score: 85/100

Q3 2020 ANI Pharmaceuticals Inc Earnings Call Transcript

Nov 05, 2020 / 03:30PM GMT
Release Date Price: $26.66 (-5.36%)
Operator

Good morning and welcome to today's program. My name is Nicole, and I'll be your conference operator. At this time, I would like to welcome everyone to the ANI Pharmaceuticals Third Quarter 2020 Earnings Results Conference Call. (Operators Instruction] As a reminder, this call is being recorded today, November 5th, 2020.

It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for ANI Pharmaceuticals. Please go ahead.

Lisa Wilson;In;Site Communications
Inc.,

Thank you, operator. Welcome to ANI Pharmaceuticals, Q3 2020 Earnings Results Call. This is Lisa Wilson of Insight Communications, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, our new President and Chief Executive Officer and Stephen Carey, Chief Financial Officer of ANI.

You could also access the webcast of this call through the Investor section of the ANI website at anipharmaceuticals.com. Before we get started, I would like to remind everyone that any statements made on today's conference call that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot